These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33363036)

  • 21. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
    Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: an update with special reference to HPV-related carcinomas.
    El-Mofty SK
    Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e377-85. PubMed ID: 24880454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic landscape and prognosis of patients with
    Fan Z; Zhang Q; Feng L; Wang L; Zhou X; Han J; Li D; Liu J; Zhang X; Zuo J; Zou X; Cai Y; Sun Y; Wang Y
    Ann Transl Med; 2022 Feb; 10(4):188. PubMed ID: 35280362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
    Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
    Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
    Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
    Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
    Meng F; Zhang L; Ren Y; Ma Q
    J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma.
    Chen Y; Kong W; Yu Z; Zhao Z
    Pathol Res Pract; 2022 Mar; 231():153761. PubMed ID: 35151031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
    Yang JW; Choi YL
    Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T; Xu S; Liu X
    Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis.
    Zhang B; Zhang L; Yue D; Li C; Zhang H; Ye J; Gao L; Zhao X; Chen C; Huo Y; Pang C; Li Y; Chen Y; Chuai S; Zhang Z; Giaccone G; Wang C
    Transl Lung Cancer Res; 2020 Aug; 9(4):1187-1201. PubMed ID: 32953497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations.
    Joshi A; Mishra R; Desai S; Chandrani P; Kore H; Sunder R; Hait S; Iyer P; Trivedi V; Choughule A; Noronha V; Joshi A; Patil V; Menon N; Kumar R; Prabhash K; Dutt A
    Oncotarget; 2021 Mar; 12(6):578-588. PubMed ID: 33796225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting the Immunological Profiles in
    Xu D; Liu S; Wu X; Marti TM; Dorn P; Schmid RA; Peng RW; Shu Y
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K; Wu Y
    BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.
    Schwaederle M; Elkin SK; Tomson BN; Carter JL; Kurzrock R
    Cell Cycle; 2015; 14(14):2355-61. PubMed ID: 26030731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma.
    Saito T; Mitomi H; Yao T
    Int J Clin Exp Pathol; 2015; 8(3):2267-73. PubMed ID: 26045734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
    Huang G; Zhang J; Gong L; Huang Y; Liu D
    BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.